Shares of Siemens Healthineers AG (ETR:SHL – Get Rating) have earned a consensus rating of “Hold” from the fifteen brokerages that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is €65.89 ($71.62).
A number of research firms have commented on SHL. Berenberg Bank set a €75.00 ($81.52) price target on Siemens Healthineers in a research report on Monday, April 4th. Nord/LB set a €60.00 ($65.22) price target on Siemens Healthineers in a research report on Tuesday, January 4th. JPMorgan Chase & Co. set a €71.10 ($77.28) price objective on Siemens Healthineers in a research note on Wednesday, March 30th. Credit Suisse Group set a €71.00 ($77.17) price objective on Siemens Healthineers in a research note on Wednesday, January 19th. Finally, Kepler Capital Markets set a €65.00 ($70.65) price objective on Siemens Healthineers in a research note on Tuesday, January 11th.
ETR SHL opened at €55.30 ($60.11) on Thursday. The business’s 50-day moving average price is €55.57 and its two-hundred day moving average price is €59.16. Siemens Healthineers has a 12 month low of €45.17 ($49.10) and a 12 month high of €67.66 ($73.54). The firm has a market capitalization of $62.08 billion and a PE ratio of 34.98. The company has a current ratio of 1.13, a quick ratio of 0.73 and a debt-to-equity ratio of 86.58.
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
- OrganiGram’s Turnaround Begins To Blossom
- Three Dividend Stocks With Growth Potential
- Exelon Stock Still Has Extraordinary Upside
- Ross Stores On The Verge Of Major Rally
- Insiders Are Selling Palo Alto Networks
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.